Splicing variants of androgen receptor in prostate cancer

Haitao Zhang1, Yang Zhan2, Xichun Liu3

  • 1Department of Pathology and Laboratory Medicine, Tulane University School of Medicine New Orleans, LA ; Department of Tulane Cancer Center New Orleans, LA.

Insights

Androgen receptor splice variants drive castration-resistant prostate cancer progression despite new therapies like abiraterone and enzalutamide. Understanding AR variants is key to overcoming treatment resistance in prostate cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Castration-resistant prostate cancer (CRPC) remains a clinical challenge.
  • Androgen receptor (AR) signaling persists in CRPC.
  • New therapies (abiraterone, enzalutamide) target AR but resistance develops.

Purpose of the Study:

  • To review the role of AR splice variants in CRPC progression.
  • To discuss the structure, activity, detection, and clinical relevance of AR variants.
  • To explore mechanisms of AR variant production.

Main Methods:

  • Literature review of studies on AR splice variants in prostate cancer.
  • Analysis of data on AR variant structure and function.
  • Examination of clinical studies investigating AR variants and treatment outcomes.

Main Results:

  • Constitutively active AR splice variants contribute to AR-driven tumor progression.
  • AR variants are detected in CRPC and associated with treatment resistance.
  • Mechanisms of AR variant production are increasingly understood.

Conclusions:

  • AR splice variants are critical drivers of treatment resistance in CRPC.
  • Targeting AR variants may offer new therapeutic strategies.
  • Further research into AR variant biology is essential for improving CRPC management.

Related Concept Videos

RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
62.0K
RNA Splicing01:32

RNA Splicing

21.2K
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
27.6K
Alternative RNA Splicing02:18

Alternative RNA Splicing

5.6K
Pre-mRNA Processing: RNA Splicing01:32

Pre-mRNA Processing: RNA Splicing

7.5K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.6K